Fundamental VR
2 known investors
Fundamental VR develops immersive extended reality (XR) training solutions for clinical and medical device professionals, enabling faster skill acquisition and competency development through interactive 3D simulations and digital twins of medical procedures.
Also known as Fundamental Surgery Β· Fundamental XR Β· FundamentalVR
Investors Β· 2
Company profile
researched Aug 2026Fundamental VR (also presenting as Fundamental XR) is a London-headquartered company that builds immersive extended-reality training for the medical sector. Its proprietary platform, Fundamental Surgery, combines virtual reality with haptic-feedback sensors so that trainees can see a virtual patient in 3D and physically feel interaction with tissue and instruments, an approach described externally as "a flight simulator for surgeons." The platform supports collaborative sessions in which teachers and students, or mentors and trainees, can practise, repeat and rehearse procedures together from different physical locations.
The product range spans virtual reality, mixed reality, augmented reality, generative-AI-supported learning, haptics, and web and mobile/tablet applications, with technology that allows conversion of the same content across immersive, app and web media. Supporting capabilities include an insights platform for tracking usage and measuring learning and assessment, ready-made or custom imaging modules that can simulate a customer's own imaging device, high-fidelity anatomy and digital twins of operating-room environments, multi-user collaboration, and enterprise security with single sign-on integration. Clinical specialties covered include orthopaedics, spine, ophthalmology, urology, robotics, injection technique and gene therapy surgical technique. The company also cites a patented Haptic Intelligence Engine and applies machine learning to skill transfer and proficiency measurement.
The business sells to life sciences corporates, medical device and pharmaceutical companies, medical robotics companies and hospital networks, and works with clinical, manufacturing and commercial growth teams within MedTech customers.
Founding story
Fundamental VR was founded by technology entrepreneur Richard Vincent, who serves as CEO and co-founder, together with co-founder Chris Scattergood; both previously worked together at SmartFusion, where Vincent was CEO and co-founder and Scattergood was CEO and founder, and Scattergood also founded Beaver Communications. Vincent has described the company's turning point as a demonstration involving a virtual knee, when the team realised users could genuinely touch and interact with a virtual patient in a VR environment, and recalls the company growing from three people with an idea to teams in London and the US.
Business model
Fundamental VR builds and licenses highly realistic VR training content and delivers it through a platform that includes an insights/learning-analytics layer; it also designs and delivers custom XR solutions for individual clients. Customers include life sciences corporates, medical device and pharmaceutical companies, medical robotics firms and hospital networks, alongside health systems such as the NHS.
Revenue is generated from licensing VR training content and platform access, and from custom XR solution development engagements for enterprise medical and life-sciences clients.
Traction
The company reports more than 500,000 training hours delivered, over 200 healthcare institutions served and reach in more than 50 countries, alongside claimed outcomes of 95% skill retention and 40% faster learning. Case studies cite a 400% reduction in physical setup assistance in robotics training and more than 30 countries serviced in ophthalmology. Investor commentary references an impressive client roster and strong growth metrics, and an employee headcount in the 21-100 range with 16% employee growth over 12 months.
Latest developments
In October 2024 the company was recorded as receiving a $5m grant, its sixth funding event. Recent activity noted by its investor Edge includes a partnership with Haply Robotics, availability on Apple Vision Pro, a feature in Forbes on pioneering innovations, and attendance at the LTEN 2024 conference. The company's website now positions the business as "Fundamental XR," spanning VR, mixed reality, augmented reality, AI, haptics and web/app delivery, with contact through a fundamentalxr.com address.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Fundamental VR was identified by Frost & Sullivan as best in class in the global VR surgical simulation and training industry and named its Company of the Year in 2023. It has won three Bold Awards, was featured in Time magazine's top 50 inventions of 2018, and was named by Sifted's audience as one of the leading medical device start-ups to watch in 2023. Commentators note the medical VR market is crowded, with the company differentiating on haptics and machine learning.
The combination of virtual reality with haptic feedback allows users to touch and interact with a virtual patient rather than only view one, which the company frames as reproducing what surgery feels like. Additional differentiators cited include the patented Haptic Intelligence Engine, optimisation for home, multi-user and mixed-use settings, digital twin and imaging fidelity, cross-medium deployment from a single content base, and professional accreditation from the Royal College of Surgeons and the American Academy of Orthopaedic Surgeons.
Technology
The platform pairs virtual reality with haptic-feedback hardware driven by a patented Haptic Intelligence Engine, adding machine learning and generative AI for deeper learning and feedback. It renders realistic anatomy and digital twins of patients, devices and operating rooms, includes ready-made or customer-specific imaging simulation, supports multi-user collaborative training, and can be deployed across VR, mixed reality, augmented reality, web browsers and native mobile or tablet apps. An insights platform tracks usage, training and assessment, and the system is designed for enterprise-grade security and single sign-on integration.
Go-to-market
The company markets directly to enterprise medical device, pharmaceutical and robotics customers and to hospital and training institutions, using client case studies across robotics, ophthalmology, injection training, gene therapy and urology, and inviting inbound enquiries via its website. Third-party accreditation from the Royal College of Surgeons and the American Academy of Orthopaedic Surgeons, a partnership with Meta, and industry awards are used as credibility signals; the company also appears at sector events such as the LTEN conference and the Virtual Medicine conference.
Surgeons, surgical trainees and other clinicians; hospital networks and health systems including the NHS; medical device, pharmaceutical, gene therapy and medical robotics companies; and MedTech clinical, manufacturing and commercial teams.
Geography
Headquartered in Farringdon, London, United Kingdom, with an expansion into and offices in the United States. The company states it reaches customers in more than 50 countries, with more than 30 countries serviced through its ophthalmology training work.
History
Beginning as a three-person idea, the company developed the Fundamental Surgery platform combining haptics with VR and grew into offices in London and the United States. It secured accreditation from the Royal College of Surgeons and the American Academy of Orthopaedic Surgeons, was featured in Time magazine's top 50 inventions of 2018, and partnered with organisations including the NHS and medical device and pharmaceutical companies to calibrate and refine the platform. The COVID-19 pandemic increased demand for remote surgical skills collaboration. EQT (via the LSP HEF 2 fund) entered as an investor in 2022, the same year the company raised a Series B, and the company subsequently extended into ophthalmology, urology, orthopaedics and robotics specialties, partnered with Meta and Haply Robotics, and launched on Apple Vision Pro.
Risks & controversies
The medical VR market is described as crowded and competitive, and new entrants continue to arrive in the virtual reality hardware space, creating pressure on differentiation. Several headline performance figures, including skill retention and learning-speed claims, originate from the company's own marketing materials.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 11
launches, deals, and filingsA $5m grant is listed as the most recent of six funding events for the company.
$5M source β
Named among leading medical device start-ups to watch based on investor feedback gathered by Sifted.
Identified as best in class in the global VR surgical simulation and training industry and named Company of the Year 2023.
Company established offices in London and the US following US expansion.
Platform accredited by the Royal College of Surgeons (England) and the American Academy of Orthopaedic Surgeons.
Medtech Insight reported the company raised $20M in a Series B round to further develop its haptic VR technology for surgical training.
$20M source β
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Fundamental VRfundamentalvr.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Fundamental VR do?
- UK-based developer of haptic-enabled VR and XR simulation used to train surgeons and medical device teams.
- Who are Fundamental VR's investors?
- Fundamental VR's investors include Brighteye Ventures, Edge VC.